US FDA approval

Aurobindo Pharma Gets U.S. FDA Nod for Asthma Inhaler

Aurobindo Pharma has received final U.S. FDA approval to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths. The generic asthma inhaler is equivalent to QVAR and is intended for the maintenance treatment of asthma. The product will be manufactured at the company’s subsidiary Aurolife Pharma’s facility in Raleigh, North Carolina, and is expected